In the US, SOLIRIS (eculizumab systemic) is a member of the drug class selective immunosuppressants and is used to treat Hemolytic Uremic Syndrome and Paroxysmal Nocturnal Hemoglobinuria.
US matches:
- Soliris
UK matches:
- Soliris (SPC)
Ingredient matches for SOLIRIS
Eculizumab
Eculizumab is reported as an ingredient of SOLIRIS in the following countries:
- Austria
- Canada
- Denmark
- France
- Germany
- Luxembourg
- Netherlands
- Spain
- Sweden
- Switzerland
- United Kingdom
- United States
International Drug Name Search
Glossary
SPC | Summary of Product Characteristics (UK) |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment